Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person The effects of trastuzumab on HER2-mediated cell signaling in CHO cells expressing human HER2
| Class:Id | LiteratureReference:9634297 |
|---|---|
| _displayName | The effects of trastuzumab on HER2-mediated cell signaling in CHO cells expressing human HER2 |
| _timestamp | 2019-01-09 20:18:26 |
| author | [Person:9634296] Maadi, Hamid [Person:9634300] Nami, Babak [Person:9634299] Tong, Junfeng [Person:9634298] Li, Gina [Person:2424447] Wang, Zhixiang |
| created | [InstanceEdit:9634301] Orlic-Milacic, Marija, 2019-01-09 |
| journal | BMC Cancer |
| pages | 238 |
| pubMedIdentifier | 29490608 |
| title | The effects of trastuzumab on HER2-mediated cell signaling in CHO cells expressing human HER2 |
| volume | 18 |
| year | 2018 |
| (literatureReference) | [Reaction:1227964] ERBB2 homodimerization [Homo sapiens] [Reaction:1248694] Trans-autophosphorylation of ERBB2 homodimer [Homo sapiens] [Reaction:9652277] ERBB2 binds trastuzumab [Homo sapiens] [Pathway:9652282] Drug-mediated inhibition of ERBB2 signaling [Homo sapiens] [Summation:9652268] ERBB2 signaling is inhibited by binding of ERBB2 to ERBB2-di... |
| [Change default viewing format] | |
No pathways have been reviewed or authored by The effects of trastuzumab on HER2-mediated cell signaling in CHO cells expressing human HER2 (9634297)
